2nd Emerging Investigators EHA-EBMT Joint Fellowship Awards in the Field of Cell Therapy and Immunotherapy
The European Society for Blood and Marrow Transplantation (EBMT) and the European Hematology Association (EHA) awarded the 2nd Emerging Investigators EHA-EBMT Joint Fellowship Awards in the Field of Cell Therapy and Immunotherapy at the 4th European CAR T-cell Meeting, held virtually on February 10-12, 2022.
Capitalizing on the success of the 1st and 2nd editions of the joint EBMT-EHA EU Meeting on CAR T-Cells held in Paris, France in February 2019 and Sitges, Spain 2020, and the first virtual edition in 2021, the two professional associations teamed up again in 2022 to bring the 4th edition of the same meeting. The meeting brought together prestigious keynote lecturers from the USA, China and Europe, senior and junior investigators interested in preclinical and clinical development of this new class of innovative therapies, all categories of healthcare professionals involved in the safe administration and delivery of CAR-T cells, and representatives of all stakeholders including patients advocates and representatives. The meeting is meant to foster interactions among delegates, and favor the development of collaborative projects across Europe and with investigators from other parts of the world.
During the meeting, EBMT and EHA jointly awarded 3 prizes of 10,000 € to support emerging researchers’ groups involved in the preclinical or clinical development of CAR T-Cell therapies or IEC based therapies at large. The awardees were selected among abstract submitters who indicated their interest in applying for the award, and were selected for an oral presentation during one of the flash-talk sessions.
The winner will be requested to send a report on the status and progress of the project for the 5th CART meeting in 2023 (extended abstract).
The Award can only be used for the professional support of the research group as such. Personal allowances are excluded.
How to Apply
Application is now closed.